Veno-venous ECLS rescue for a heart transplant recipient with COVID-19, a case report
The potential for increased rates of morbidity of SARS-CoV-2 within immunocompromised populations has been of concern since the pandemic's onset. Transplant providers and patients can face particularly challenging situations, in the current settings as data continues to emerge for the prevention and treatment of the immunocompromised subpopulation. This case report details a patient 9-months post orthotopic heart transplant that developed SARS-CoV-2 infection despite two prior doses of the Pfizer-BioNtech COVID-19 vaccine, and had successful rescue from refractory hypoxemia with veno-venous extracorporeal membrane oxygenation (VV ECLS).
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:39 |
---|---|
Enthalten in: |
Perfusion - 39(2024), 3 vom: 25. März, Seite 631-634 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Copeland, Hannah [VerfasserIn] |
---|
Links: |
---|
Themen: |
Acute respiratory distress syndrome |
---|
Anmerkungen: |
Date Completed 18.03.2024 Date Revised 18.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1177/02676591231154120 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM352258659 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM352258659 | ||
003 | DE-627 | ||
005 | 20240318233603.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1177/02676591231154120 |2 doi | |
028 | 5 | 2 | |a pubmed24n1334.xml |
035 | |a (DE-627)NLM352258659 | ||
035 | |a (NLM)36715461 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Copeland, Hannah |e verfasserin |4 aut | |
245 | 1 | 0 | |a Veno-venous ECLS rescue for a heart transplant recipient with COVID-19, a case report |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 18.03.2024 | ||
500 | |a Date Revised 18.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a The potential for increased rates of morbidity of SARS-CoV-2 within immunocompromised populations has been of concern since the pandemic's onset. Transplant providers and patients can face particularly challenging situations, in the current settings as data continues to emerge for the prevention and treatment of the immunocompromised subpopulation. This case report details a patient 9-months post orthotopic heart transplant that developed SARS-CoV-2 infection despite two prior doses of the Pfizer-BioNtech COVID-19 vaccine, and had successful rescue from refractory hypoxemia with veno-venous extracorporeal membrane oxygenation (VV ECLS) | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Journal Article | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a Extracorporeal membrane oxygenation | |
650 | 4 | |a acute respiratory distress syndrome | |
650 | 4 | |a extracorporeal life support | |
650 | 4 | |a heart transplant | |
650 | 4 | |a immunocompromised | |
650 | 7 | |a BNT162 Vaccine |2 NLM | |
700 | 1 | |a Baran, David A |e verfasserin |4 aut | |
700 | 1 | |a Morton, John |e verfasserin |4 aut | |
700 | 1 | |a Rodriguez, Vicente |e verfasserin |4 aut | |
700 | 1 | |a Fernandes, Eustace |e verfasserin |4 aut | |
700 | 1 | |a Mohammed, Asim |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Perfusion |d 1990 |g 39(2024), 3 vom: 25. März, Seite 631-634 |w (DE-627)NLM074653768 |x 1477-111X |7 nnns |
773 | 1 | 8 | |g volume:39 |g year:2024 |g number:3 |g day:25 |g month:03 |g pages:631-634 |
856 | 4 | 0 | |u http://dx.doi.org/10.1177/02676591231154120 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 39 |j 2024 |e 3 |b 25 |c 03 |h 631-634 |